Literature DB >> 7680841

Treatment of pregnant alcohol-consuming rats with buspirone: effects on serotonin and 5-hydroxyindoleacetic acid content in offspring.

N F Tajuddin1, M J Druse.   

Abstract

This laboratory previously demonstrated that in utero ethanol exposure markedly impairs the development of the serotonergic system in rat brain. Developmental abnormalities could be detected as early as G15 in the brainstem and G19 in the cortex. Because of the importance of fetal serotonin (5-HT) and 5-HT1A receptors for the normal development of 5-HT containing neurons, we initiated studies to determine whether administration of a 5-HT1A agonist, buspirone, to pregnant rats could overcome the adverse effects of in utero ethanol exposure on the developing serotonergic system in offspring. Female, Sprague-Dawley rats were given daily subcutaneous injections of buspirone (4.5 mg/kg) from gestational day 13 (G13) to G20. 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) content were determined in the cortex and cortical regions. These experiments demonstrated that the ethanol-associated abnormalities in the development of the serotonergic system can be partially overcome by in utero exposure to buspirone. Specifically, whereas untreated ethanol rats had a deficiency of 5-HT and/or 5-HIAA in whole cortex on PN5, and in the motor cortex on PN19 and 35, no significant differences were detected in these regions of the age-matched offspring of buspirone-treated, ethanol-fed rats. In contrast, the 5-HT and 5-HIAA deficiency in the somatosensory cortex of 19-day-old offspring of ethanol-fed rats was not corrected by in utero buspirone treatment. These results suggest that the abnormal development of cortical projections of serotonergic neurons may be due in part to the low fetal 5-HT content in ethanol-exposed rats and may potentially be overcome by in utero treatment with a 5-HT1A agonist.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680841     DOI: 10.1111/j.1530-0277.1993.tb00734.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  7 in total

Review 1.  Developmental pharmacodynamics: implications for child and adolescent psychopharmacology.

Authors:  N Carrey; S Kutcher
Journal:  J Psychiatry Neurosci       Date:  1998-11       Impact factor: 6.186

2.  S100B-mediated protection against the pro-apoptotic effects of ethanol on fetal rhombencephalic neurons.

Authors:  Mary J Druse; Roberta A Gillespie; Nuzhath F Tajuddin; Megan Rich
Journal:  Brain Res       Date:  2007-03-13       Impact factor: 3.252

3.  Effects of prenatal ethanol exposure on regulation of basal hypothalamic-pituitary-adrenal activity and hippocampal 5-HT1A receptor mRNA levels in female rats across the estrous cycle.

Authors:  J H Sliwowska; N Lan; F Yamashita; A G Halpert; V Viau; J Weinberg
Journal:  Psychoneuroendocrinology       Date:  2008-07-30       Impact factor: 4.905

Review 4.  Prenatal alcohol exposure: fetal programming and later life vulnerability to stress, depression and anxiety disorders.

Authors:  Kim G C Hellemans; Joanna H Sliwowska; Pamela Verma; Joanne Weinberg
Journal:  Neurosci Biobehav Rev       Date:  2009-06-21       Impact factor: 8.989

5.  Fetal alcohol spectrum disorder-associated depression: evidence for reductions in the levels of brain-derived neurotrophic factor in a mouse model.

Authors:  Kevin K Caldwell; S Sheema; Rodrigo D Paz; Sabrina L Samudio-Ruiz; Mary H Laughlin; Nathan E Spence; Michael J Roehlk; Sara N Alcon; Andrea M Allan
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

Review 6.  Prenatal alcohol exposure: foetal programming, the hypothalamic-pituitary-adrenal axis and sex differences in outcome.

Authors:  J Weinberg; J H Sliwowska; N Lan; K G C Hellemans
Journal:  J Neuroendocrinol       Date:  2008-02-08       Impact factor: 3.627

Review 7.  Serotonergic Neuroplasticity in Alcohol Addiction.

Authors:  Arnauld Belmer; Omkar L Patkar; Kim M Pitman; Selena E Bartlett
Journal:  Brain Plast       Date:  2016-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.